Remove 2012 Remove Licensing Remove Molecular Biology
article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates. This enabled the Basel start-up ecosystem to grow considerably and consistently, with a strong acceleration in the last five to 10 years.

Drugs 147
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Journal of Molecular Biology (1961).

DNA 91
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. PNAS (2012).

DNA 52